Leukemia Dokter Terbaik di Israel - TOP-20 dokter

Spesialis leukemia terkemuka di Sourasky Medical Center (Ichilov) – rumah sakit terbesar dan tercanggih di Israel.

• Pengalaman lebih dari 25 tahun di bidang hematologi dan onkologi
• Menyelesaikan pelatihan fellowship di pusat internasional bergengsi di New York
• Berfokus pada metode medis terbaru untuk pengobatan leukemia
• Menangani sejumlah besar kasus kanker darah yang kompleks

Dr. Ram telah melakukan beberapa ratus transplantasi sel punca, sebuah pengobatan utama untuk leukemia, di Sourasky Medical Center.

• Sertifikasi dewan dalam Hematologi, Onkologi Medis, dan Penyakit Dalam
• Penulisan lebih dari 30 artikel ilmiah dan bab buku teks medis
• Pelatihan fellowship dalam Hematologi dan Onkologi di Westchester Medical Center
• Penyelesaian masa residensi di State University of New York di Brooklyn

Kepala Onkohematologi Anak di Rumah Sakit Anak Dana Dwek – Dr. El Hasid spesialis dalam transplantasi sumsum tulang dan darah tali pusat untuk anak-anak.

• Melakukan 300+ prosedur transplantasi
• Menerbitkan 50+ makalah penelitian dan 40 laporan medis
• Menempuh pelatihan di Rumah Sakit City of Hope di Los Angeles
• Menjadi anggota American Hematology Association

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Shapira adalah spesialis senior transplantasi sumsum tulang di Sourasky Medical Center yang bergengsi di Tel Aviv.

• Lulus dari Fakultas Kedokteran Hebrew University pada tahun 1999
• Menyelesaikan pelatihan spesialis penyakit dalam di Hadassah Medical Center
• Menjadi dokter senior di departemen Transplantasi Sumsum Tulang di Hadassah
• Fasih berbahasa Inggris dan Ibrani untuk pasien internasional

Kepala Institut Hemato-Onkologi di Ichilov Medical Center – Profesor Aviv spesialis dalam leukemia dan ahli transplantasi sumsum tulang.

• 31 tahun pengalaman dalam onkohematologi
• Memimpin Departemen Transplantasi Sumsum Tulang
• Dokter senior di Ichilov sejak 2003
• Ahli yang diakui dalam limfoma dan leukemia

Memimpin departemen hematologi onkologi anak di Sourasky Medical Center, pusat utama untuk menangani leukemia masa kanak-kanak di Israel.

• Berpengalaman lebih dari satu dekade dalam spesialisasi kanker darah pada anak
• Fellowship hematologi onkologi anak di Schneider Children's Medical Center
• Pelatihan khusus di luar negeri dalam onkologi tulang dan jaringan lunak di Italia
• Mengoordinasikan pengobatan sarkoma untuk anak-anak, menggabungkan onkologi anak dengan ortopedi
• Anggota Masyarakat Hematologi Onkologi Anak Israel

Fokus penelitian dan perawatan Dr. Herishanu adalah pada leukemia limfositik kronis, leukemia yang paling umum terjadi pada orang dewasa. Beliau telah menerima lebih dari sepuluh penghargaan nasional dan internasional atas karyanya di bidang ini.

• Ahli hematologi senior di Sourasky Medical Center, Tel Aviv
• Anggota profesional di Asosiasi Hematologi Israel dan Amerika
• Menyelesaikan residensi hematologi di Tel Aviv Medical Center
• Menerbitkan banyak karya ilmiah mengenai pengobatan dan penelitian CLL

Terdaftar sebagai salah satu dokter terbaik di Israel versi Forbes, Dr. Gal Goldstein memimpin Departemen Onkologi dan Hemato-Onkologi Anak di Hadassah Medical Center.

• Lebih dari 20 tahun spesialisasi dalam hemato-onkologi anak
• Ahli dalam transplantasi sumsum tulang haploidentik
• Fokus pada retinoblastoma dan pengobatan presisi
• Anggota dari empat asosiasi onkologi anak internasional
• Menempuh pendidikan di Universitas Tel Aviv

Profesor Zila Zuckerman adalah spesialis hematologi dan transplantologi yang berdedikasi di Rambam Medical Center.

• Ahli dalam kanker darah dewasa dan anak-anak
• Fokus pada transplantasi sumsum tulang untuk leukemia
• Bagian dari tim pusat medis akademik utama

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Memimpin Departemen Hematologi di Pusat Medis Hadassah, spesialis dalam perawatan lanjutan untuk kanker darah.

• Profesor dengan pengalaman lebih dari tiga dekade dalam penyakit darah ganas
• Menjalani pelatihan selama tiga tahun di Memorial Sloan-Kettering Cancer Center di New York
• Ahli dalam transplantasi sumsum tulang dan terapi gen baru
• Wanita pertama yang menjabat sebagai Dekan Fakultas Kedokteran Hadassah
• Menerima penghargaan Healing with the Heart atas perawatan pasien yang luar biasa

Dr. Stepensky telah melakukan lebih dari 3.500 transplantasi sumsum tulang dan diakui oleh Forbes sebagai salah satu dokter terbaik.

• Spesialisasi dalam mengobati anak-anak dengan leukemia dan kanker darah langka
• 20 tahun praktik berdedikasi dalam hematologi pediatrik
• Pasien dan orang tua memanggilnya dokter yang 'mentransplantasikan kehidupan'

Dr. Spielberg adalah seorang onkohematolog yang berspesialisasi dalam kanker darah di Pusat Medis Assuta.

• Keahlian difokuskan khusus pada leukemia dan kelainan darah lainnya
• Berbasis di rumah sakit swasta terkemuka di Israel, Pusat Medis Assuta
• Memberikan perawatan kanker terintegrasi dengan akses ke diagnostik tingkat lanjut

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.